Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
WorkCompWire
Article
WorkCompWire: Michael Valasek: Ensuring a Quality IME Result: Three Players in the Process
A certain amount of contention has come to surround the independent medical examination (IME) process.
Mitchell
News Release
Pennsylvania SB 936 Advances—Press Conference on Opioids Follows
During a voting meeting on January 23, 2018, the Pennsylvania House Labor and Industry Committee passed out SB 936.
Workers' Comp
Article
CMS Commercial Repayment Center (CRC) Contractor Transition
Keep current with new legislation and its potential effect on your organization.
Workers' Comp
Article
CMS Commercial Repayment Center (CRC) Contractor Transition
Keep current with new legislation and its potential effect on your organization.
Mitchell
Article
Survey Results: The Future of Technology in Workers’ Compensation
The workers’ compensation industry in general has been conservative about adopting new technologies.
Workers' Comp
White Paper
A Prescription for Fighting Opioid Use Disorder
Understanding and Planning To best respond to the crisis, we need to be clear about what opioid use disorder (OUD) is and how we identify